Evidence map›Paper›PMID 39291158›Full record

ReviewDigital health

Digital measurement of mobility in pulmonary arterial hypertension: A structured review of an emerging area.

Erin Robertson, Nader Naghavi, Matthew F Wipperman, Katie Tuckwell, Muhammad Effendi, Rinol Alaj, Jacek Urbanek, David Lederer, Laura Fredenburgh, Samuel Stuart

Abstract readReview
In one paragraph

Review in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Remote exercise assessment in pulmonary hypertension.Current opinion in pulmonary medicine · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Erin RobertsonRegeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
Nader NaghaviRegeneron Pharmaceuticals Inc., Tarrytown, NY, USA.ORCID https://orcid.org/0000-0002-3273-7213
Matthew F WippermanRegeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
Katie TuckwellRegeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
Muhammad EffendiRegeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
Rinol AlajRegeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
Jacek UrbanekRegeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
David LedererRegeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
Laura FredenburghRegeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
Samuel StuartRegeneron Pharmaceuticals Inc., Tarrytown, NY, USA.ORCID https://orcid.org/0000-0001-6846-9372

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review examined literature that has examined mobility in pulmonary arterial hypertension (PAH) using digital technology. Specifically, the review focussed on: (a) digital mobility measurement in PAH; (b) commonly reported mobility outcomes in PAH; (c) PAH specific impact on mobility outcomes; and (d) recommendations concerning protocols for mobility measurement in PAH. PubMed, Scopus, and Medline databases were searched. Two independent reviewers screened articles that described objective measurement of mobility in PAH using digital technology. Twenty-one articles were screened, and 16 articles met the inclusion/exclusion criteria and were reviewed. Current methodologies for mobility measurement in PAH with digital technologies are discussed. In brief, the reviewed evidence demonstrated that there is a lack of standardisation across studies for instrumentation, outcomes, and interpretation in PAH. The validity and reliability of digital approaches were insufficiently reported in all studies. Future research is required to standardise digital mobility measurement and characterise mobility impairments in PAH across clinical and real-world settings. The reviewed evidence suggests that digital mobility outcomes may be useful clinical measures and may be impaired in PAH, but further research is required to accurately and robustly establish findings. Recommendations are provided for future studies that encompass comprehensive reporting, validation, and measurement.

Indexed as

digital health technologygaitinertial sensorsMobilityphysical activitypulmonary arterial hypertensionwearables

Identifiers

PMID39291158
PMCPMC11406665

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.